↓ Skip to main content

Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

Overview of attention for article published in International Journal of Clinical Oncology, June 2004
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
11 Mendeley
Title
Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck
Published in
International Journal of Clinical Oncology, June 2004
DOI 10.1007/s10147-004-0390-8
Pubmed ID
Authors

Mamoru Tsukuda, Yasukazu Mikami, Yuji Tanigaki, Hideaki Katori, Choichi Horiuchi, Yoichi Ikeda, Takahide Taguchi, Machiko Ono, Takahumi Yoshida, Yasunori Sakuma, Ken Aikoh

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 27%
Student > Ph. D. Student 2 18%
Professor > Associate Professor 2 18%
Researcher 1 9%
Lecturer 1 9%
Other 0 0%
Unknown 2 18%
Readers by discipline Count As %
Medicine and Dentistry 8 73%
Unknown 3 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 August 2016.
All research outputs
#7,566,705
of 23,079,238 outputs
Outputs from International Journal of Clinical Oncology
#150
of 923 outputs
Outputs of similar age
#18,804
of 57,901 outputs
Outputs of similar age from International Journal of Clinical Oncology
#1
of 1 outputs
Altmetric has tracked 23,079,238 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 923 research outputs from this source. They receive a mean Attention Score of 3.6. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 57,901 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them